Christopher U. Missling

CIK: 0001196573

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (16.7%)

Derivative conversions

Awards (A)8 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AVXL

ANAVEX LIFE SCIENCES CORP.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

AVXL
ANAVEX LIFE SCIENCES CORP.
Jan 6, 2026
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-
AVXL
ANAVEX LIFE SCIENCES CORP.
Oct 2, 2025
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-
AVXL
ANAVEX LIFE SCIENCES CORP.
Sep 11, 2025
Exercise(M)
Direct
187.5K shares at avg. $5.04$945K
AVXL
ANAVEX LIFE SCIENCES CORP.
Sep 11, 2025
Tax Payment(F)
Direct
145K shares at avg. $9.58$1.4M
AVXL
ANAVEX LIFE SCIENCES CORP.
Aug 20, 2025
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-
AVXL
ANAVEX LIFE SCIENCES CORP.
Apr 28, 2025
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-
AVXL
ANAVEX LIFE SCIENCES CORP.
Mar 24, 2025
Exercise(M)
Direct
500K shares at avg. $0.92$460K
AVXL
ANAVEX LIFE SCIENCES CORP.
Mar 24, 2025
Tax Payment(F)
Direct
282.5K shares at avg. $9.63$2.7M
AVXL
ANAVEX LIFE SCIENCES CORP.
Jan 15, 2025
Award(A)
Stock Option (Right to Buy)
Direct
166.7K shares-
AVXL
ANAVEX LIFE SCIENCES CORP.
Jan 15, 2025
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-
AVXL
ANAVEX LIFE SCIENCES CORP.
Dec 19, 2024
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-
AVXL
ANAVEX LIFE SCIENCES CORP.
Nov 19, 2024
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-

		Type	Shares	Price		Ownership
Jan 6, 2026	AVXL ANAVEX LIFE SCIENCES CORP.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct
Oct 2, 2025	AVXL ANAVEX LIFE SCIENCES CORP.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct
Sep 11, 2025	AVXL ANAVEX LIFE SCIENCES CORP.	Exercise(M)	187,500	$5.04	$945,000	Direct
Sep 11, 2025	AVXL ANAVEX LIFE SCIENCES CORP.	Tax Payment(F)	145,048	$9.58	$1,389,560	Direct
Aug 20, 2025	AVXL ANAVEX LIFE SCIENCES CORP.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct
Apr 28, 2025	AVXL ANAVEX LIFE SCIENCES CORP.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct
Mar 24, 2025	AVXL ANAVEX LIFE SCIENCES CORP.	Exercise(M)	500,000	$0.92	$460,000	Direct
Mar 24, 2025	AVXL ANAVEX LIFE SCIENCES CORP.	Tax Payment(F)	282,497	$9.63	$2,720,446	Direct
Jan 15, 2025	AVXL ANAVEX LIFE SCIENCES CORP.	Award(A) Stock Option (Right to Buy)	166,666	-	-	Direct
Jan 15, 2025	AVXL ANAVEX LIFE SCIENCES CORP.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct
Dec 19, 2024	AVXL ANAVEX LIFE SCIENCES CORP.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct
Nov 19, 2024	AVXL ANAVEX LIFE SCIENCES CORP.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct

1-12 of 12 transactions

About MISSLING CHRISTOPHER U

MISSLING CHRISTOPHER U (SEC CIK 0001196573) files insider reports with the SEC as President and CEO of ANAVEX LIFE SCIENCES CORP. (AVXL).

Signal8 holds 9 ownership filings by MISSLING CHRISTOPHER U, all Form 4s, filed between Dec 6, 2024 and Jan 9, 2026. Those filings report 12 transactions, from Nov 19, 2024 to Jan 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MISSLING CHRISTOPHER U's filings is in NEW YORK, NY.

Recent filings by MISSLING CHRISTOPHER U

Jan 6, 2026: Grant or award of AVXL derivative securities (Form 4, code A).
Oct 2, 2025: Grant or award of AVXL derivative securities (Form 4, code A).
Sep 11, 2025: Option exercise of AVXL shares (Form 4, code M).
Sep 11, 2025: Tax withholding of AVXL shares (Form 4, code F).
Aug 20, 2025: Grant or award of AVXL derivative securities (Form 4, code A).

Other insiders filing for ANAVEX LIFE SCIENCES CORP. (AVXL)

Senderowicz Adrian, Director
Patel Gautam, Director
Boenisch Sandra, PFO & Treasurer
Kellmeyer Terrie, Interim CEO
Paeger Axel, Director
Thomas Steffen, Director

How to read Form 4 transaction codes